ShankusEnem CRO

ShankusEnem CRO is the clinical research division of Enem Nostrum Remedies Pvt. Ltd., specializing in bioavailability (BA) and bioequivalence (BE) studies for generic drug development. The organization provides end-to-end CRO services, including clinical study execution, bioanalytical testing, and regulatory support for pharmaceutical companies. Its infrastructure includes a 108-bed clinical research facility, advanced bioanalytical laboratories equipped with multiple LC-MS/MS and ICP-MS systems, and a volunteer database of over 12,000 participants. ShankusEnem supports studies across a range of therapeutic areas, including cardiovascular diseases, diabetes, oncology, antibiotics, and nutraceuticals, while catering to regulatory requirements from agencies such as CDSCO, USFDA, ANVISA, GCC, and NPRA.